NEW YORK, NY / ACCESSWIRE / January 28, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fiat Chrysler Automobiles N.V. ("Fiat Chrysler" or the "Company") (NYSE: FCAU) and certain of its officers, on behalf of shareholders who purchased Fiat Chrysler securities between February 26, 2016 and November 20, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/fcau.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Fiat employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with International Union, United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat official were aware of and authorized the scheme; and (3) due to the foregoing, defendants' statements about Fiat's receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/fcau or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Fiat Chrysler you have until January 31, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 574142

NEW YORK, NY / ACCESSWIRE / January 28, 2020 / Rhombus, the leading platform for advertising around social embeds, today announced Mike Garite as its new Vice President of Product and Katie Black as its new Director of Publisher Development. This follows on the heels of Rhombus bringing on board Jeff Rich-former Teads, Complex and Uproxx executive-as EVP of Revenue.

Former MLB Advanced Media and Kargo leaders join social embed platform

"We're seeing incredible traction in the market with both publishers and advertisers because our platform is clearly resonating with their need for innovation. That's why building a leadership team that completely understands and knows how to execute our vision is critical to our success heading into 2020," said Abe Storey, CEO at Rhombus. "I'm thrilled that we're further rounding out the team with Mike and Katie. While Mike's data driven technology experience brings a fresh perspective to product innovation in our space, Katie's experience building relationships with publishers in the ad tech space will take our supply partnerships to a whole new level."

Mike Garite, New VP of Product

At Rhombus, Garite will be responsible for bringing data-driven decisions to bear in shaping Rhombus' platform and capabilities. Prior to Rhombus, Garite most recently served as the Director of Front End Development for the baseball data team at MLB Advanced Media, where he directed a team of engineers that dealt with all things data. Garite was responsible for building new features and functionality for products that generated billions of impressions in traffic annually such as Stats, Scoreboards and Gameday.

"After working as an early employee at several successful startups, agencies and larger companies such as eBay and Pandora, what I've realized excites me the most is working with an incredible group of people who are all working towards something that they truly believe will change the landscape of an industry," said Mike Garite, VP of Product. "Rhombus has a super unique value proposition that no other company is able to offer and the ability to develop a product around this data is an incredible opportunity."

Katie Black, New Director of Publisher Development

At Rhombus, Black will be responsible for onboarding new publisher partners, with whom Rhombus will run contextual advertising around their social embeds. She will also serve as publishers' main product advocate, ensuring Rhombus' platform continues to deliver valuable capabilities and benefits that drive their business forward. Prior to Rhombus, Katie managed publisher partnerships at mobile-only advertising company Kargo.

"Within minutes of meeting with Abe and his team, I completely understood the gap in the market that they were filling for publishers. That's what got me fired up about Rhombus," said Katie Black, Director of Publisher Development. "The team truly believes in providing simple yet impactful solutions, and I'm excited to help build partnerships that will continue to accelerate Rhombus' footprint in the market."

To learn more, visit www.rhombusads.com.

About Rhombus

Rhombus is The Social Embed Platform. We've built the first advertising marketplace for social content on digital sites. Over 36% of articles contain social embeds, and we analyze and classify them by social platform, keywords, hashtags, accounts, platforms, and interest segments. For advertisers, Rhombus offers a better way to reach their audience with contextually relevant social content in a brand safe, fraud free, premium environment. For Publishers, our technology is designed to help them monetize the social embeds already curated by their journalists. For consumers, we are creating a privacy-minded, unobtrusive advertising experience.

RHOMBUS

Buy Social. On Digital.

To learn more, email contact@rhombusads.com or visit www.rhombusads.com.

# # #

CONTACT INFORMATION

Nikki Reyes

WIT Strategy for Rhombus

nreyes@witstrategy.com

(408) 499-0033

SOURCE: Rhombus

ReleaseID: 574323

Latin Artists Emilia, Luis Figueroa and MYA to Perform at MAXIM's Annual Event During the Biggest Weekend in Sports

NEW YORK, NY / ACCESSWIRE / January 28, 2020 / Today, In the Know Experiences and MAXIM announced Megan Thee Stallion, Russ, Chase B, Emilia, Luis Figueroa and MYA as the newest additions to the dynamic lineup of performers for the 2020 MAXIM Big Game Experience taking place on Saturday, February 1, 2020. The star-studded evening will feature previously announced artists including GRAMMY Award-Winning performers The Chainsmokers, Miami's own Rick Ross, and DJ duo the Lost Kings. In collaboration with Columbia Records, the highly anticipated annual event will play host to the biggest names in sports, entertainment and music at a one-of-a-kind, exclusive 40,000 square waterfront foot pop-up venue on Biscayne Bay, which is accessible by land, air or sea.

Known for her chart-topping hit "Hot Girl Summer," renowned rapper, Megan Thee Stallion, will take center stage for an energetic live performance. Guests will also get to hear Atlanta rapper, Russ, perform some of his multi-platinum hits as he celebrates the release of his brand-new album "SHAKE THE SNOW GLOBE," which officially drops on January 31st.

In the spirit of the evening's Havana Nights theme, organizers have announced three talented Latin performers will make their Big Game Weekend debut. Making a big impact through various hit singles, such as Billboard Argentina's Hot 100 track "Recalienta", Emilia is one of the top female stars to watch in Latin music. Multi-Platinum Puerto Rican singer-songwriter, Luis Figueroa, who just released his new single, "Te Deseo" will also perform. Luis' star is quickly ascending and he's on track to become the next big Latin pop sensation following the success of his Billboard chart debut, "La Especialista" earlier this year. Lastly, MYA composed of multifaceted actors, singer-songwriters, pop duo Maxi Espíndola and Agus Bernasconi, became a Latin pop sensation with their hit single "Te Olvidaré" alongside Pedro Capó.

The soiree will feature interactive brand activations encouraging guests to immerse themselves within the many live experiences. Newly announced brand partners include Absolut Elyx introducing a one-of-a-kind Ford Bronco beverage bar, wellness brand, and Liquid I.V., offering customized cocktails, using their all-natural hydration product in drinks such as the LIVtini and the LIVarita, and a customized ball pit for guests to enjoy. Cantu Beauty will also be offering samples and swag as they unveil their newly launched Avocado Collection with an interactive swing photo moment at this year's event. The Avocado Collection was created with all hair types in mind to help hydrate, define, and seal in moisture.

Various food options will be offered throughout the night including former NFLer Al "Bubba" Baker's Bubba's Boneless Ribs, wings, fries and sides from Texas founded restaurant Wingstop, Miami based food truck TAIGOs Tacos and the ultimate late-night pizza from Pizza Hut. Additionally, the Chainsmokers' own craft tequila brand JAJA Tequila will serve as the official tequila of the night. Attendees will also be gifted with product giveaways from brand partners including Defiance Fuel, Rowdy Energy, KJL CBD, and Zen, among others.

For additional details, sponsorship opportunities, hospitality, and experiential table and ticket packages or to inquire about programming opportunities at the one-of-a-kind venue, please email maximsb@itkexp.com or visit https://maximsb2020.com/.

ABOUT MAXIM

MAXIM is a luxury lifestyle brand with a voice that is aspirational and inspirational. It publishes 11 editions distributed in 75 countries. MAXIM celebrates the best of the best by covering the most beautiful women in the world, exotic destinations, supercars, as well as self-made business titans and superstar athletes.

ABOUT IN THE KNOW EXPERIENCES

In the Know Experiences is a full-service lifestyle company, with strong areas of expertise in the luxury travel, private events, fashion, nightlife and marketing industries. With over a decade of experience, we specialize in managing front of house operations and overseeing ticket, table and hospitality sales for premier events around the globe. Past notable events that In the Know Experiences' handled all ticketing and event hospitality include The Rolling Stone Super Bowl Party in various locations, the MAXIM Big Game Party in New York City and Atlanta, Playboy Super Bowl 50 Party in San Francisco and more…

MEDIA CONTACTS:

Sunshine Sachs
212-691-2800
maxim@sunshinesachs.com

SOURCE: MAXIM

ReleaseID: 574303

SEATTLE, WA / ACCESSWIRE / January 28, 2020 / Infosys (NYSE:INFY), a global leader in next-generation digital services and consulting announced it will introduce the new Infosys C+C Award at the Unleashing the Power of CIOs + CMOs event on January 30. The international award, managed by WONGDOODY, Infosys' award-winning creative agency and human experience company, will honor transformative collaborations between chief marketing officers (CMOs) and chief information officers (CIOs), as they partner to elevate customer experience at their organizations.

Traditionally, CMOs are responsible for company brand and consumer needs, and they control the majority of the customer experience (CX) budget. Yet, a recent Nielsen report showed that, "Seventy-four percent of CMOs have little to no confidence they have the right technology to achieve their marketing goals.

Meanwhile, many CIOs share ownership of CX and they often feel unsupported, without design resources or creative insights. Frequently, there is pressure to deploy new technologies quickly, with limited budgets, and without in-depth analysis of enterprise-wide implications.

The new Infosys C+C Award is part of a CMO+CIO partner program created by Infosys to offer resources that foster effective relationships between C-level marketing and technology leaders to successfully navigate digital transformation. The January 30 event will give tips for how to win the inaugural competition, and also feature a CMO predictions report from featured speaker Shar VanBoskirk, vice president and principal analyst at Forrester, serving CMO Professionals. Consulting expert Kevin Carroll will discuss best practices for C-suite collaboration.

Ravi Kumar S, President, Infosys, said, "Effective collaboration between CMOs and CIOs is critical for digital transformation. Leveraging our creative firm WONGDOODY, we're delighted to launch the first Infosys C+C Award to celebrate global thought leaders that are integrating technology and marketing across digital enterprise to help bridge this gap."

Ben Wiener, CEO, WONGDOODY, said "CMOs and CIOs are becoming more interdependent because consumers expect innovative user experiences that understand their needs. And this is impossible without the right technologies. The new Infosys C+C Award recognizes C-suite leaders who have mastered the powerful relationship between marketing and technology to create customer loyalty in changing markets."

Infosys C+C Award Categories:

The Infosys C+C Award will evaluate global companies with a minimum of $250M in revenue, and will include categories for the following CMO and CIO partnerships:

C+C Relationship Changes: Celebrates innovative changes for collaboration in budget allocation, cross-training, communication, decision-making or strategic planning.
C+C Experience Innovators: Highlights partnerships, work, and accomplishments that transform the customer experience.
C+C Company Transformers: Recognizes relationships that have company-wide impacts.

Important Dates and Information:

The Infosys C+C Award opens globally in January, and the submission deadline is June 2020. Winners will be announced in September at the Infosys Confluence conference. For more competition details, visit: https://cpluscaward.com/. To register for Unleashing the Power of CIOs and CMOs, go here.

Safe Harbor

Certain statements mentioned in this presentation concerning our future growth prospects are forward-looking statements regarding our future business expectations intended to qualify for the 'safe harbor' under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2019. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company's filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

For further information, please contact: PR_Global@infosys.com

About Us

About Infosys Ltd

Infosys is a global leader in next-generation digital services and consulting. We enable clients in 46 countries to navigate their digital transformation. With over three decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem.

Visit www.infosys.com to see how Infosys (NYSE:INFY) can help your enterprise navigate your next.

Contacts

PR_Global@infosys.com

SOURCE: Infosys

ReleaseID: 574279

JUPITER, FL / ACCESSWIRE / January 28, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scales, today announced that its President and Chief Executive Officer, Mark Emalfarb, was interviewed by Liz Claman "The Claman Countdown" from FOX Business Network on Monday, January 27, 2020.

To view the interview, please click on the following link:

https://video.foxbusiness.com/v/6126957311001/#sp=show-clips

A permanent copy of this interview can be found at:

https://www.dyadic.com/investors/media-center/video-gallery/

About Liz Claman

Liz Claman joined FOX Business Network (FBN) as an anchor in October 2007. She anchors Claman Countdown (weekdays 3-4PM/ET). Her October debut on FBN included an exclusive interview with Berkshire Hathaway CEO and legendary investor Warren Buffett. Throughout her tenure at FBN, Claman has conducted exclusive interviews with every U.S. Treasury Secretary from John Snow to Paul O'Neill, Larry Summers, Timothy Geithner and Jack Lew. Claman has brought a roster of business leaders including JP Morgan CEO Jamie Dimon, Starbucks CEO Howard Schultz, Twitter co-founders Jack Dorsey, Evan Williams and Biz Stone, Google/Alphabet Executive Chairman Eric Schmidt, and Microsoft founder Bill Gates to Fox Business viewers as well as world leaders, including Israeli Prime Minister Benjamin Netanyahu and Ukraine President Petro Poroshenko. Prior to joining FBN, Claman served as an anchor at CNBC, most recently anchoring Morning Call and Wake Up Call, Market Watch, and Today's Business. During her time at CNBC, Claman landed the first one-hour live one-on-one interview with Warren Buffett. Before CNBC, Claman, a two-time Emmy Award winner, served as an anchor and reporter for Boston's WHDH-TV (NBC). She was also a contributing correspondent for NBC's syndicated daytime program RealLife. Prior to that, she anchored a two-hour daily talk show, The Morning Exchange for WEWS-TV (ABC) in Cleveland. She received an Emmy for her work on The Morning Exchange. A graduate of the University of California, Berkeley and the Sorbonne in Paris, Claman began her on-air career at WSYX-TV (ABC) in Columbus, OH as a reporter and later a weekend anchor. Earlier, she was a news associate for KCBS-TV (CBS) in Los Angeles where she was the youngest person in the station's history to win a local Emmy Award for Best Spot News Producer. Claman is a member of the Board of Directors of the American Theatre Wing and is a Tony Award voter. She is an active fundraiser for Building Homes for Heroes, an organization that builds mortgage-free homes for severely wounded soldiers returning from Iraq and Afghanistan. She has completed 7 triathlons and one New York City marathon.

About Dyadic International, Inc.

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila, named C1. The C1 microorganism, which enables the development and large scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (such as virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Additionally, and more recently, Dyadic is also beginning to explore the use of its C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of Adeno-associated viral vectors (AAV), certain metabolites and other biologic products. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers and, hopefully, improve access and cost to patients and the healthcare system, but most importantly save lives.

Please visit Dyadic's website at http://www.dyadic.com for additional information, including details regarding Dyadic's plans for its biopharmaceutical business.

Safe Harbor Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding Dyadic International's expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in the Company's most recent filings with the SEC. Dyadic assumes no obligation to update publicly any such forward-looking statements, whether as a result of new information, future events or otherwise. For a more complete description of the risks that could cause our actual results to differ from our current expectations, please see the section entitled "Risk Factors" in Dyadic's annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as such factors may be updated from time to time in Dyadic's periodic filings with the SEC, which are accessible on the SEC's website at http://www.dyadic.com

Contact:

Dyadic International, Inc.

Mark Emalfarb, CEO
Phone: +1 (561) 743-8333
Email: memalfarb@dyadic.com

SOURCE: Dyadic International, Inc.

ReleaseID: 574324

Cub Energy Inc. Announces Spudding of the M-30 well in Eastern Ukraine

HOUSTON, TX / ACCESSWIRE / January 28, 2020 / Cub Energy Inc. ("Cub" or the "Company") (TSXV:KUB), a Ukraine-focused upstream oil and gas company, announces that KUB-Gas LLC ("Kub-Gas"), Cub's 35%-owned subsidiary which owns and operates the eastern Ukraine licences, has commenced drilling of the Makeevskoye-30 ("M-30") well. The M-30 well is planned to a total depth of 1,985 metres to evaluate several prospective horizons. The M-30 well is funded through existing Kub-Gas cashflow.

Mikhail Afendikov, Chairman and CEO of Cub said: "We are pleased to announce the spudding of the M-30 well in eastern Ukraine. The M-30 well will be the first well drilled on the producing M field in over three years after recent successful recompletions on the M and O fields at Kub-Gas."

About Cub Energy Inc.

Cub Energy Inc. (TSX-V: KUB) is an upstream oil and gas company, with a proven track record of exploration and production cost efficiency in Ukraine. The Company's strategy is to implement western technology and capital, combined with local expertise and ownership, to increase value in its undeveloped land base, creating and further building a portfolio of producing oil and gas assets within a high pricing environment.

For further information please contact us or visit our website: www.cubenergyinc.com.

Mikhail Afendikov
Chairman and Chief Executive Officer
(713) 677-0439
mikhail.afendikov@cubenergyinc.com

Patrick McGrath
Chief Financial Officer
(713) 577-1948
patrick.mcgrath@cubenergyinc.com

The disclosure in this press release is prepared in accordance with NI 51-101 standards.

Reader Advisory

Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Cub believes that the expectations reflected in the forward-looking information are reasonable; however there can be no assurance those expectations will prove to be correct. We cannot guarantee future results, performance or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.

Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: general economic conditions in Ukraine, the Black Sea Region and globally; political unrest and security concerns in Ukraine; industry conditions, including fluctuations in the prices of natural gas and foreign currency; governmental regulation of the natural gas industry, including environmental regulation; unanticipated operating events or performance which can reduce production or cause production to be shut in or delayed; failure to obtain industry partner and other fourth party consents and approvals, if and when required; competition for and/or inability to retain drilling rigs and other services; the availability of capital on acceptable terms; the need to obtain required approvals from regulatory authorities; stock market volatility; volatility in market prices for natural gas; liabilities inherent in natural gas operations; competition for, among other things, capital, acquisitions of reserves, undeveloped lands, skilled personnel and supplies; incorrect assessments of the value of acquisitions; geological, technical, drilling, processing and transportation problems; changes in tax laws and incentive programs relating to the natural gas industry; failure to realize the anticipated benefits of acquisitions and dispositions; and the other factors. Readers are cautioned that this list of risk factors should not be construed as exhaustive.

This cautionary statement expressly qualifies the forward-looking information contained in this news release. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Cub Energy Inc.

ReleaseID: 574322

Name Change Reflects Broad Clinical Applications of Fibroblasts

HOUSTON, TX / ACCESSWIRE / January 28, 2020 / SpinalCyte, LLC, today introduced a new company name, FibroGenesis that reflects the expansive intellectual property portfolio, including the development of a cure for degenerative disc disease and cell therapy treatment options for other chronic diseases. The new entity will be wholly owned by SpinalCyte, LLC.

"We began our work with fibroblasts in the area of degenerative disc disease and soon discovered the unique properties of this cell source and its positive impact across a spectrum of other disease paths", commented Pete O'Heeron. "This new entity will provide a broader platform for our intellectual property and delivers an umbrella for our future work to attack a variety of chronic diseases."

About Degenerative Disc Disease

Degenerative disc disease (DDD) is a condition in which a patient's spinal disc breaks down and can begin to collapse. It is estimated that 85% of people over the age of 50 have evidence of disc degeneration and over 1.3 million procedures a year are performed to treat the disease. The most common treatments for patients with DDD are either discectomy or spinal fusion. Discectomy is the partial or full removal of the degenerated disc to decompress and relieve the nervous system but can cause long term spinal pain. In a spinal fusion procedure, the entire disc is removed and the two adjacent vertebrae are fused together. It often increases strain on the adjacent discs and surrounding tissues leading to further degeneration.

About CybroCell

CybroCell is the first off-the-shelf allogenic human dermal fibroblast (HDF) product for the treatment of degenerative disc disease. FibroGenesis's Phase 1/Phase 2 clinical trial for injected human dermal fibroblasts in the treatment of DDD demonstrated after 12 months, patients injected with CybroCell had sustained improvement in pain relief and increased back mobility.

About FibroGenesis

Based in Houston, Texas, FibroGenesis, is a regenerative medicine company developing an innovative solution for spinal replacement using human dermal fibroblasts. Currently, FibroGenesis holds 180 U.S. and international issued patents and patents pending and issued across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, Parkinson's, Chronic Traumatic Encephalopathy, Cancer, Diabetes, Liver Failure and Heart Failure. Funded entirely by angel investors, FibroGenesis represents the next generation of medical advancement in cell therapy. Visit www.Fibro-Genesis.com.

Contact:
Clinical Contact: info@Fibro-Genesis.com

SOURCE: FibroGenesis

ReleaseID: 574308

HERZLIYA, ISRAEL and CALGARY, AB / ACCESSWIRE / January 28, 2020 / InnoCan Pharma Corporation ("InnoCan" or the "Company") (CSE:INNO) announced today that it has signed a distribution agreement with Active Therapeutics Ltd ("Active Therapeutics"), part of Natural Resources (NW) LTD ("Natural Resources") of Lancashire, United Kingdom to distribute InnoCan's cutting edge scientifically CBD based Derma Cosmetic products in the UK and Ireland markets.

Active Therapeutics Ltd. has vast experience in pharmaceuticals and healthcare including the brand portfolios of Merck, GSK, Astra Zeneca, 3M, and STADA. This experience has enabled Active Therapeutics to view the market with a long-term vision and introduce innovative and technologically advanced CBD based products to the growing demands of the UK and Ireland markets.

The CBD skincare market is projected to bring in US$959 million in sales by 2024, according to the leading cannabis market intelligence and strategic consultancy firm, Prohibition Partners latest report, The Impact Series: Disrupting Beauty, released on January 23, 2020. According to the report, the largest CBD markets in Europe today are the United Kingdom (UK) and Austria, each of which made up an early US $80 million market in 2018. The UK is expected to remain a market leader over the medium-term. Source: Bright field group, Press Release, Europe CBD Market through 2023.

Iris Bincovich, InnoCan's CEO said, "We are excited to present our first distribution agreement in the large, sophisticated UK and Irish market. Active Therapeutics is an exceptional distributor that will ensure that our products attain maximum visibility. With manufacturing agreements in the US and Europe and this first distribution agreement in a key market, InnoCan is rigorously executing its business plan for full commercialization in 2020.

Zahid Atcha Co-Founder, Active Therapeutics Ltd., said, " We are very excited to be working with Innocan Pharma's world class team and truly believe that customers will benefit from this relationship as we aim to introduce and educate consumers of the advanced scientific approach of Innocan Pharma's CBD portfolio."

About InnoCan Pharma Corporation

InnoCan Pharma brings pharmacological rigour to the burgeoning CBD marketplace. The founders and officers of InnoCan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally. InnoCan's business has three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. http://innocanpharma.com/

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond InnoCan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by InnoCan, including expectations and assumptions concerning the anticipated benefits of the product markets, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact InnoCan can also be found in InnoCan's public reports and filings which are available under InnoCan's profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. InnoCan Pharma does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

For further information, please contact:

For InnoCan Pharma Corporation:

Iris Bincovich, CEO
+972-54-3012842
info@innocanpharma.com

For Investor Relations: Proconsul Capital Ltd.

Andreas Curkovic 416-577-9927

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: InnoCan Pharma Corp.

ReleaseID: 574319

A construction-focused technology company secured the high-profile coverage after working with the Newswire Team.

NEW YORK, NY / ACCESSWIRE / January 28, 2020 / A construction technology company landed media coverage from Business Insider after becoming a Newswire Earned Media Advantage Guided Tour customer. The construction technology company helps contractors easily process their payment. With the help of the Newswire team, who implemented a strategic Earned Media Advantage Plan (EMAP), the company was recognized by Business Insider. The plan, developed by an Earned Media Advantage Strategist (EMAS), created a unique strategy for the construction technology company to help promote its brand message to top media contacts and target their customer audience.

Construction Technology Company Featured on Business Insider Thanks to Newswire's Earned Media Advantage Guided Tour

"Focusing and implementing the right plan and sending it out to the right people at the right time has attributed to this monumental win for the construction technology company," said Charlie Terenzio, Director of Earned Media Strategy at Newswire, "The strategy ‘customerized' by our strategist caught Business Insider's attention, resulting in the company being highlighted in an article."

The construction industry has had issues with payment errors, leaving contractors unpaid on time and lost payment records. Through the construction technology company's product and messaging, these pain points were addressed for contractors and their employers. Taking this into account, the strategist was able to integrate the company's unique messaging to send to the right audience at the right time through the right mediums. As a result, the Guided Tour has become the paving way to more earned media mentions and strategic organization to create the right roadmap to achieve their media and marketing goals.

"As a cost-efficient option opposed to hiring an FTE or agency, Newswire's Earned Media Advantage Guided Tour has been the construction technology company's way of being able to cut the time it takes to achieve media recognition and reach the right audience," said Terenzio.

Aside from the construction technology company, other companies in the technology and construction industry have come to embrace the Earned Media Advantage Guided Tour as a way to achieve the Earned Media Advantage: greater brand awareness, increased traffic, greater return on media and marketing communications spend, and increased sales. Connecting with an EMAS to create and implement an EMAP has been adapted by company c-suite level executives.

Discover How the Earned Media Advantage is Transforming Business today and learn how to compete in the industry.

About Newswire

Newswire delivers press release and multimedia distribution software and services (SaaS) that empower the Earned Media Advantage: greater brand awareness, increased traffic, greater return on media and marketing communications spend and a competitive edge. With over a decade of experience, Newswire continues to provide its customers with the ability to deliver the right message to the right audience at the right time through the right medium.

To learn and experience Newswire, visit http://www.newswire.com.

Contact Information​​

​Anthony Santiago
Vice President of Marketing
Newswire
Office: 917-398-2622
​anthony@newswire.com

SOURCE: Newswire

ReleaseID: 574220